Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious Uveitis.
Saved in:
| Title: | Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious Uveitis. |
|---|---|
| Authors: | Gangaputra SS; Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Newcomb CW; Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ying GS; Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA., Dreger KA; Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Population, Family, and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Fitzgerald T; Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA., Artornsombudh P; Department of Ophthalmology, Somdech Phra Pinklao Hospital, Royal Thai Navy, Bangkok, Thailand.; Department of Ophthalmology, Chulalongkorn University, Bangkok, Thailand., Kothari S; Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA., Liesegang TL; Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon, USA., Rosenbaum JT; Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon, USA.; Legacy Devers Eye Institute, Portland, Oregon, USA., Sen HN; Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA., Suhler EB; Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon, USA.; Department of Ophthalmology, Portland Veterans Affairs Medical Center, Portland, Oregon, USA.; Oregon Health and Science University- Portland State University School of Public Health, Portland, Oregon, USA., Thorne JE; Department of Ophthalmology, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Bhatt NP; Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA., Foster CS; Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, USA., Jabs DA; Department of Ophthalmology, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Center for Clinical Trials and Evidence Synthesis, Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Levy-Clarke GA; Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.; Department of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, West Virginia, USA., Lowder CY; Department of Ophthalmology Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA., Goldstein DA; Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Holland GN; Department of Ophthalmology, Ocular Inflammatory Disease Center, Jules Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Jaffe GJ; Department of Ophthalmology, Duke University, Durham, North Carolina, USA., Davis JL; Department of Ophthalmology, University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Miami, Florida, USA., Acharya NR; Department of Ophthalmology, F.I. Proctor Foundation, University of California San Francisco School of Medicine, San Francisco, California, USA., Latkany PA; Department of Ophthalmology, New York Eye and Ear Infirmary/Icahn School of Medicine at Mt. Sinai, New York, New York, USA., Read RW; Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama, USA., Garg SJ; Mid-Atlantic Retina, The Retina Service of Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Liederman YI; Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Buchanich JM; School of Public Health, Center for Occupational Biostatistics and Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Kempen JH; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA.; Department of Ophthalmology and Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.; Department of Ophthalmology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.; MCM Eye Unit, MyungSung Christian Medical Center (MCM) Comprehensive Specialized Hospital and MyungSung Medical College, Addis Ababa, Ethiopia.; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA., For The Systemic Immunosuppressive Therapy For Eye Diseases Site Cohort Study Research Group |
| Source: | Ocular immunology and inflammation [Ocul Immunol Inflamm] 2025 Aug; Vol. 33 (6), pp. 948-956. Date of Electronic Publication: 2025 Apr 15. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-5078 (Electronic) Linking ISSN: 09273948 NLM ISO Abbreviation: Ocul Immunol Inflamm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1744-5078 |
|---|---|
| DOI: | 10.1080/09273948.2025.2479802 |
